Cencora (COR) Income from Non-Controlling Interests (2018 - 2026)
Cencora (COR) posted Income from Non-Controlling Interests of -$11.8 million for Q1 2026, down 282.19% on a QoQ basis from $6.5 million in Q4 2025, and down 2500.0% year-over-year from $491833.3 in Q1 2025.
Cencora (COR) Income from Non-Controlling Interests (2018 - 2026) Analysis & Trends
Cencora's Income from Non-Controlling Interests history runs 9 years deep, the most recent figure standing at -$11.8 million for Q1 2026.
- Quarterly Income from Non-Controlling Interests fell 2500.0% year-over-year to -$11.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (down 71.62% YoY) and the FY2025 annual result came in at $13.6 million, up 34.39% from the prior year.
- Income from Non-Controlling Interests was -$11.8 million for Q1 2026 at Cencora, down from $6.5 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $7.2 million in Q1 2022 and bottomed at -$43.8 million in Q2 2022.
- A 5-year average of -$1.6 million and a median of $1.5 million in 2023 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2024 — Income from Non-Controlling Interests jumped 1222.55% — and 2026, when it tumbled 2500.0%.
- Cencora's Income from Non-Controlling Interests stood at -$3.6 million in 2022, then surged by 142.18% to $1.5 million in 2023, then surged by 239.46% to $5.1 million in 2024, then increased by 26.57% to $6.5 million in 2025, then sank by 282.19% to -$11.8 million in 2026.
- Business Quant data shows COR's Income from Non-Controlling Interests at -$11.8 million in Q1 2026, $6.5 million in Q4 2025, and $6.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 173.00 Mn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | -11.80 Mn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | -19.00 Mn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 5.00 Mn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 30,000.00 |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | - |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | - |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.80 Mn |
| Dec 31, 2025 | 6.48 Mn |
| Sep 30, 2025 | 6.63 Mn |
| Jun 30, 2025 | 2.35 Mn |
| Mar 31, 2025 | -454,000.00 |
| Dec 31, 2024 | 5.12 Mn |
| Sep 30, 2024 | 4.08 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Mar 31, 2024 | 430,000.00 |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -368,000.00 |
| Mar 31, 2023 | -7.19 Mn |
| Dec 31, 2022 | -3.58 Mn |
| Sep 30, 2022 | 3.94 Mn |
| Jun 30, 2022 | -43.76 Mn |
| Mar 31, 2022 | 7.23 Mn |
| Dec 31, 2021 | 311,000.00 |
| Sep 30, 2021 | -1.25 Mn |
| Jun 30, 2021 | 3.33 Mn |